• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6 0.38% $5.24

CLARITY PHARMACEUTICALS LTD

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CU6
CU6 - ASX Charts
7 8 9
18/06/24 537 170K
18/06/24 Last post  flotsam222 Comments Created with Sketch.  537  Views Created with Sketch.  170K 
CU6
CU6 - Media and Industry News
2 3 4
17/06/24 209 85K
17/06/24 Last post  flotsam222 Comments Created with Sketch.  209  Views Created with Sketch.  85K 
CU6 14/06/24 11 4.2K
Metals & Mining SECTOR NEWS

Sun Silver's 6,216g/t silver (Ag) intercept within a high-grade target zone

SS1
18 Jun 2024
SUN SILVER LIMITED
14/06/24 Last post  stevenlcs Comments Created with Sketch.  11  Views Created with Sketch.  4.2K 
CU6
Research/Valuation
7 8 9
07/06/24 527 176K
07/06/24 Last post  Hingdog Comments Created with Sketch.  527  Views Created with Sketch.  176K 
CU6
News: CU6 Clarity Pharmaceuticals Confirms No Supply Disruptions For Clinical Trials
07/06/24 0 206
07/06/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  206 
CU6 05/06/24 1 695
05/06/24 Last post  tonks306511 Comments Created with Sketch.  1  Views Created with Sketch.  695 
CU6 05/06/24 0 333
05/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  333 
CU6 30/05/24 50 15K
30/05/24 Last post  flotsam222 Comments Created with Sketch.  50  Views Created with Sketch.  15K 

See All Discussions arrow Created with Sketch.

Timeline

Clarity Confirms No Supply Disruptions for Clinical Trials
07 Jun 10:05
 
Cleansing Notice
05 Jun 08:54
 
Application for quotation of securities - CU6
05 Jun 08:53
 
Clarity strengthens Cu-64 network with new supply agreement
30 May 08:23
 
Change of Director's Interest Notice - Rob Thomas
22 May 16:11
 
Cleansing Notice
17 May 13:32
 
View More arrow Created with Sketch.
(20min delay)
Last
$5.24
Change
0.020(0.38%)
Mkt cap ! $1.632B
Open High Low Value Volume
$5.26 $5.29 $5.13 $4.811M 927.1K

Buyers (Bids)

No. Vol. Price($)
2 4354 $5.18
 

Sellers (Offers)

Price($) Vol. No.
$5.24 4999 1
View Market Depth
Last trade - 16.10pm 18/06/2024 (20 minute delay) ?
Last
$5.22
  Change
0.020 ( 0.01 %)
Open High Low Volume
$5.27 $5.28 $5.14 147907
Last updated 15.59pm 18/06/2024 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.